Web1 day ago · In other developments, Altamira Therapeutics (NASDAQ:CYTO) skyrocketed after releasing phase 2 results on its vertigo medication. ... The firm had set a price target of $65 per share, representing ... WebAltamira Therapeutics Ltd. (CYTO) NasdaqCM - NasdaqCM Real Time Price. Currency in USD. Add to watchlist. 1.6300 +0.2500 (+18.12%) At close: 03:59PM EDT. 1.6200 -0.01 …
Making Sense Of Altamira Therapeutics Ltd.’s (NASDAQ:CYTO) …
Web1 day ago · Today’s news has shares of CYTO stock seeing heavy trading volume. As of this writing, more than 2.1 million shares of the stock have changed hands. For … WebApr 3, 2024 · CYTO stock closed at $1.28 and is down -$0.07 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours. CYTO has a poor overall score of 9 meaning the stock holds a better value than just 9% of stocks at its current price. how to calculate cesarean rate
2024-04-13 NDAQ:GDTC Press Release CytoMed Therapeutics …
WebAltamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda) (CYTO) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebApr 9, 2024 · The performance represented a 4.9% gain from Kshs 6.5 per share recorded the previous week, taking it to a 0.9% Year-to-Date (YTD) increase from Kshs 6.78 per share recorded on 3 rd January 2024. In addition, the performance represented a 65.8% Inception-to-Date (ITD) loss from the Kshs 20.0 price. The dividend yield currently … WebApr 6, 2024 · A high-level overview of Altamira Therapeutics Ltd. (CYTO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. mfk collection